4//SEC Filing
GOTTSCHALK ADRIAN 4
Accession 0001562180-23-001675
CIK 0001822462other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:23 PM ET
Size
19.1 KB
Accession
0001562180-23-001675
Insider Transaction Report
Form 4
GOTTSCHALK ADRIAN
DirectorChief Executive Officer
Transactions
- Other
Common Stock
2022-10-25−4,371→ 444,333 total(indirect: See Footnote) - Gift
Common Stock
2023-02-17−4,371→ 63,000 total - Other
Common Stock
2023-02-17+184,939→ 448,704 total(indirect: See Footnote) - Gift
Common Stock
2022-02-10−123,479→ 23,000 total - Other
Common Stock
2022-10-25+4,371→ 67,371 total - Gift
Common Stock
2022-02-10+123,479→ 448,704 total(indirect: See Footnote) - Gift
Common Stock
2023-02-17+4,371→ 448,704 total(indirect: See Footnote) - Other
Common Stock
2023-02-17−184,939→ 448,704 total(indirect: See Footnote)
Footnotes (10)
- [F1]Reported late due to administrative error.
- [F10]Consists of 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 338,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
- [F2]On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration.
- [F3]Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
- [F4]Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person.
- [F5]The reported holdings include 40,000 shares of the Issuer's Common Stock acquired by the Reporting Person through an option exercise reported on Form 4 on September 19, 2022.
- [F6]Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
- [F7]On February 17, 2023, the Reporting Person transferred 4,371 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration.
- [F8]Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 153,075 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
- [F9]Transfer of assets between the the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Adrian H. Gottschalk Living Trust dated September 8, 2009.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001828724
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:23 PM ET
- Size
- 19.1 KB